TITLE

Pre-dialysis insulin: a new concept to treat an old problem

AUTHOR(S)
Marchant, Karen
PUB. DATE
September 2009
SOURCE
British Journal of Nursing;9/24/2009, Vol. 18 Issue 17, p1044
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Diabetes and chronic kidney disease are two disease processes that remain with the patient from diagnosis to the end of their lives. The field of diabetes and renal failure is a complex area, merging together these two chronic diseases, each a speciality in its own right. Patients with diabetes need to start dialysis much earlier than those without diabetes due to the cumulative effect of proteinuria and its associated symptoms. The single largest cause of end-stage renal disease continues to be diabetes and within the field of renal nursing, we have seen an increase in the number of patients with diabetes entering the dialysis program in recent years. The author's personal experience is that once on hemodialysis, we have seen traditional treatments fail to meet the individual needs of this cohort and have devised a program of insulin delivery that appears to fill this gap.
ACCESSION #
44391255

 

Related Articles

  • Neutrophil Gelatinase-Associated Lipocalin in Dialyzed Patients Is Related to Residual Renal Function, Type of Renal Replacement Therapy and Inflammation. Malyszko, Jolanta; Malyszko, Jacek S.; Koc-Zorawska, Ewa; Kozminski, Piotr; Mysliwiec, Michal // Kidney & Blood Pressure Research;2009, Vol. 32 Issue 6, p464 

    Neutrophil gelatinase-associated lipocalin (NGAL) has recently been proved useful in the quantitation of chronic kidney disease. A cross-sectional study was performed to assess NGAL in serum, urine and ultrafiltrate in relation to the type of renal replacement therapy and NGAL correlations with...

  • Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Renzo Mignani; Sandro Feriozzi; Antonio Pisani; Antonio Cioni; Cristina Comotti; Maria Cossu; Annalisa Foschi; Antonio Giudicissi; Eliana Gotti; Vito Antonio Lozupone; Francesco Marchini; Fabrizio Martinelli; Francesco Bianco; Vincenzo Panichi; Deni Aldo Procaccini; Elena Ragazzoni; Andrea Serra; Fausto Soliani; Letizia Spinelli; Giacomo Torti // Nephrology Dialysis Transplantation;May2008, Vol. 23 Issue 5, p1628 

    Background. In Fabry disease, end-stage renal disease (ESRD) and severe neurologic and cardiac complications represent the leading causes of late morbidity and mortality. A comprehensive Italian nationwide survey study was conducted to explore changes in cardiac status and renal allograft...

  • Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Tamura, Manjula Kurella; Yaffe, Kristine // Kidney International;Jan2011, Vol. 79 Issue 1, p14 

    Cognitive impairment, including dementia, is a common but poorly recognized problem among patients with end-stage renal disease (ESRD), affecting 16-38% of patients. Dementia is associated with high risks of death, dialysis withdrawal, hospitalization, and disability among patients with ESRD;...

  • Chapter 3: Assessment of lipid status in children with CKD.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p280 

    The article presents information on a study related to children with newly identified chronic kidney disease (CDK) and recommends evaluation with a lipid profile. Topics include prediction of lipid levels in children for future cardiovascular events, relationship between dyslipidemias and...

  • F. Clinical Renal Pharmacology and Therapeutics.  // Kidney;Nov/Dec2009, Vol. 18 Issue 6, p342 

    The article presents studies related to clinical renal pharmacology and therapeutics. One study discovers that Avosentan, an endothelin-A antagonist, lessens albumin excretion in diabetics with macroalbuminuria. Another study examines the long-term effects of aldosterone antagonists on patients...

  • Low Molecular Weight Heparins and Glomerular Filtration Rate: A Report to be Considered. Fabbian, Fabio; De Giorgi, Alfredo; Pala, Marco; Tiseo, Ruana; Portaluppi, Francesco; Imberti, Davide; Manfredini, Roberto // Current Vascular Pharmacology;Nov2011, Vol. 9 Issue 6, p693 

    Venous thromboembolism is a common condition and low molecular weight heparins (LMWHs) are widely used for its treatment. Chronic kidney disease (CKD) is also a frequent disease especially in subjects with comorbidities admitted to internal medicine wards. LMWHs are eliminated by the kidney and...

  • Commerce in transplantation in Third World countries. Chugh, Kripal S.; Jha, Vivekanand; Chugh, K S; Jha, V // Kidney International;May1996, Vol. 49 Issue 5, p1181 

    The article discusses the commerce of kidney transplantation in third world countries. Chronic kidney failure is a devastating social, economical and medical problem for patients and their families. The treatment for kidney failure entails a choice between dialysis and transplantation. Factors...

  • The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. Morton, R. L.; Tong, A.; Howard, K.; Snelling, P.; Webster, A. C. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/13/2010, Vol. 340 Issue 7742, p350 

    The article discusses a study which examined the factors that influence the decision making process for chronic kidney disease (CKD) treatment. Study authors conducted a review of 18 studies about the treatment of CKD, including dialysis, transplantation and palliative management. Such studies...

  • Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort. Pernod, G.; Bosson, J.-L.; Golshayan, D.; Barro, C.; Forneris, G.; Martina, G.; Bonfant, G.; Hurot, J.-M.; Turc-Baron, C.; Jouet, C.; Theytaz, J.; Jeantet, A.; Wauters, J.-P.; Cordonnier, D. // Kidney International;Apr2006, Vol. 69 Issue 8, p1424 

    Cardiovascular disease (CVD) remains the major cause of death in patients with end-stage renal disease (ESRD). Traditional risk factors do not explain the high prevalence of CVD in this population, and other non-traditional cardiovascular (CV) risk markers have now been described. Therefore, the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics